Degradation and Accumulation of Oxidized Proteins in Age-Related Diseases

Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases

Volumn , Issue , 2006, Pages 527-562

  Voss, Peter ^a   Grune, Tilman ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Oxidative stress and amino acid modifications; Oxidized protein degradation; Oxidized proteins in age related diseases

Indexed keywords

EID: 84889336346     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471973122.ch17     Document Type: Chapter

References (255)

1. Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamurea T., Tanahashi N., Yoshimura T., Tanaka K., Ichihara A. (1994). Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem 115: 257-269.
2. Alam Z.I., Halliwell B., Jenner P. (2000). No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease. J Neurochem 75: 840-846.
3. Alvarez B., Radi R. (2003). Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25: 295-311.
4. Amici A., Levine R.L., Tsai L., Stadtman E.R. (1989). Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem 264: 3341-3346.
5. Anselmi B., Conconi M., Veyrat-Durebex C., Turlin E., Bilville F., Alliot J., Friguet B. (1998). Dietary self-selection can compensate an age-related decrease of rat liver 20S proteasome activity observed with standard diet. J Gerontol A Biol Sci Med Sci 53: B173-B179.
6. Armstrong R.C., Swallow A.J. (1969). Pulse-and gamma-radiolysis of aqueous solutions of tryptophan. Radiations Res 41: 563-579.
7. Bajorek M., Glickman M.H. (2004). Keepers at the final gates: Regulatory complexes and gating of the proteasomal channel. Cell Mol Life Sci 61: 1-10.
8. Balazy M., Kaminski K.M., Mao K., Tan J., Wolin M.S. (1998). S-Nitroglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide. J Biol Chem 273: 32009-32015.
9. Barnham K.J., Masters C.L., Bush A.I. (2004). Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3: 205-214.
10. Baudry M., DuBrin R., Beasley L., Leon M., Lynch G. (1986). Low lewels of calpain activity in Chiroptera brain: Implications for mechanisms of aging. Neurobiol Aging 7: 255-258.
11. Baumeister W., Walz J., Zühl F., Seemuller E. (1998). The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92: 367-380.
12. Beedholm R., Clark B.F.C., Rattan S.I.S. (2004). Mild heat stress stimulates 20S proteasome and its 11S activator in human fibroblasts undergoing aging in vitro. Cell Stress Chaperones 9: 49-57.
13. Benaroud J.N., Tarcsa E., Cascio P., Goldberg A.L. (2001). The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie 83: 311-318.
14. Berlett B.S., Levine R.L., Stadtman E.R. (1996). Comparison of the effects of ozone on the modification of amino acid residues in glutamine synthetase and bovine serum albumin. J Biol Chem 271: 4177-4182.
15. Bidere N., Lorenzo H.K., Carmona S., Laforge M., Harper F., Dumont C., Senik A. (2003). Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278: 31401-31411.
16. Bose S., Stratford F.L., Broadfoot K.I., Mason G.G., Rivett A.J. (2004). Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem J 378(Pt 1): 177-184.
17. Bossy-Wetzel E., Schwarzenbacher R., Lipton S.A. (2004). Molecular pathways to neurodegeneration. Nat Med 10: S2-S9.
18. Bota D.A., Davies K.J.A. (2002). Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 4: 673-680.
19. Braun B.C., Glickman M., Kraft R., Dahlmann B., Kloetzel P.M., Finley D., Schmidt M. (1999). The base of the proteasome regulatory particle exhibits chaperone-like activity. Nature Cell Biol 1: 221-226.
20. Brodie A.E., Reed D.J. (1990). Cellular recovery of glyceraldehyde-3-phosphate dehydrogenase activity and thiol status after exposure to hydroperoxides. Arch Biochem Biophys 276: 212-218.
21. Buchczyk D.P., Grune T., Sies H., Klotz L.O. (2003). Modifications of glyceraldehyde-3-phosphate dehydrogenase induced by increasing concentrations of peroxynitrite: Early recognition by 20S proteasome. Biol Chem 384: 237-241.
22. Bulteau A., Petropoulos I., Friguet B. (2000). Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 35: 767-777.
23. Burns K., Martinon F., Tschopp J. (2003). New insights into the mechanism of IL-2beta maturation. Curr Opin Immunol 12: 26-30.
24. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. (1991). Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci USA 88: 3633-3636.
25. Carrard G., Bulteau A.L., Petropoulos I., Friguet B. (2002). Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34: 1461-1474.
26. Cellek S. (2004). Point of NO return for nitrergic nerves in diabetes: A new insight into diabetic complications. Curr Pharm Des 10: 3683-3695.
27. Chondrogianni N., Fracoulis E.G., Gonos E.S. (2002). Protein degradation during aging: the lysosome-, the calpain-and the proteasome-dependent cellular proteolytic systems. Biogerontology 3: 121-123.
28. Chu-Ping M., Slaughter C.A., DeMartino G.N. (1992). Purification and characterization of a protein inhibitor of the 20S proteasome (macropain). Biochim Biophys Acta 1119: 303-311.
29. Ciechanover A., Brundin P. (2003). The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron 40: 427-446.
30. Cirman T., Oresic K., Mazovec G.D., Turk V., Reed J.C., Myers R.M., Salvesen T.S., Turk B. (2004). Selective disruption of lysozymes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J BiolChem 279: 3578-3587.
31. Claverol S., Burlet-Schiltz O., Girbal-Neuhauser E., Gairin J.E., Monsarrat B. (2002). Mapping and structural dissection of human 20S proteasome using proteomic approaches. Mol Cell Proteomics 1: 567-578.
32. Cole N.B., Murphy D.D. (2002). The cell biology of alpha-synuclein: A sticky problem? Neuromolecular Med 1: 95-109.
33. Conconi M., Petropoulos I., Emod I., Turlin E., Biville F., Friguet B. (1998). Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem J 333: 407-415.
34. Conconi M., Szweda L.I., Levine R.L., Stadtman E.R., Friguet B. (1996). Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Mol Biol Rep 24: 45-50.
35. Coux O., Tanaka K., Goldberg A.L. (1996). Structure and function of the 20S and 26S proteasomes. Ann Rev Biochem 65: 801-847.
36. Creeth J.M., Cooper B., Donald A.S.R., Clamp J.R. (1983). Studies on the limited degradation of mucous glycoproteins. Biochem J 211: 323-332.
37. Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., Chin W., Geller B., Hayden D.L., Schoenfeld D.A., Hosler B.A., Horvitz H.R., Brown R.H. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 41: 210-221.
38. Cuervo A.M., Knecht E., Terlecky S.R., Dice J.F. (1995). Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol 269: C1200-C1208.
39. Cuzzocrea S., McDonald M.C., Mazzon E., Mota-Filipe H., Centorrino T., Terranova M.L., Ciccolo A., Britti D., Caputi A.P., Thiemermann C. (2001). Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut 48: 478-488.
40. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colombo R. (2003). Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-28.
41. Dare E., Gotz M.E., Zhivotovski B., Manzo L., Cettatelli S. (2000). Antioxidants J811 and 17-ß-estradiol protect cerebellar granule cells from methylmercury-induced apoptotic cell death. J Neurosci Res 62: 557-565.
42. Davies K.J. (2001). Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310.
43. Davies K.J.A., Delsignore M.E., Lin S.W. (1987). Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J Biol Chem 262: 9902-9907.
44. Davies S., Ramsden D.B. (2001). Huntington's disease. Neurobiol Dis 3: 3-15.
45. De Wit R., Capello A., Boonstra J., Verkleij A.J., Post J.A. (2000). Hydrogen peroxide inhibits epidermal growth factor receptor internalization in human fibroblasts. J Cell Physiol 178: 17-27.
46. De Wit R., Makkinje M., Boonstra J., Verkleij A.J., Post J.A. (2001). Hydrogen peroxide reversibly inhibits epidermal growth factor (EGF) receptor internalization and coincident ubiquitination of the EGF receptor and Eps15. FASEB J 15: 305-308.
47. Dean R.T. (1975a). Concerning a possible mechanism for selective capture of cytoplasmic proteins by lysosomes. Biochem Biophys Res Commun 67: 604-609.
48. Dean R.T. (1975b). Direct evidence of importance of lysosomes in degradation of intracellular proteins. Nature 257: 414-416.
49. DeGracia D.J., Montie H.L. (2004). Cerebral ischemia and the unfolded protein response. J Neurochem 91: 1-8.
50. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. (1991). Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975.
51. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. (1989). Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389.
52. Dhaliwal B.S., Steinbrecher U.P. (2000). Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally. J Lipid Res 41: 1658-1665.
53. Driscoll J., Brown M.G., Finley D., Monaco J.J. (1993). MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365: 262-264.
54. Dice J.F. (1993). Cellular and molecular mechanisms of aging. Physiol Rev 73: 149-159.
55. Dunlop R.A., Rodgers K.J., Dean R.T. (2002). Recent developments in the intracellular degradation of oxidized proteins. Free Rad Biol Med 33: 894-906.
56. Easton C.J. (1997). Free-radical reactions in the synthesis of alpha-amino acids and derivatives. Chem Rev 97: 53-82.
57. Ebadi M., Srinivasan S.K., Baxi M.D. (1996). Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 48: 1-19.
58. Emerit J., Edeas M., Bricaire F. (2004). Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58: 39-46.
59. Enenkel C., Lehmann A., Kloetzel P.-M. (1998). Subcellular distribution of proteasomes implicates a major location of protein degradation in the nuclear envelope-ER network in yeast. EMBO J 17: 6144-6154.
60. Engelhard V.H. (1994). Structure of peptides associated with MHC class I molecules. Curr Opin Immun 6: 13-23.
61. Esterbauer H., Schur R.J., Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
62. Farrer L.A., Cupples L.A., Haines J.L., Jyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Rich N., van Duijn C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356.
63. Fenteany G., Standaert R.F., Lane W.S., Choi S., Corey E.J., Schreiber S.L. (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726-731.
64. Finkel T. (2000). Redox-dependent signal transduction. FEBS Lett 476: 52-54.
65. Fischer U., Janicke R.U., Schulze-Osthoff K. (2003). Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
66. Friguet B., Stadtman E.R., Szweda L.I. (1994). Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal: Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 269: 21639-21643.
67. Friguet B., Szweda L.I. (1997). Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett 405: 21-25.
68. Gaczynska M., Rock K.L., Goldberg A.L. (1993). γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365: 264-267.
69. Gardner R.C., Assinder S.J., Christie G., Mason G.G., Markwell R., Wadsworth H., McLaughlin M., King R., Chabot-Fletcher M.C., Beton J.J., Allsop D., Rivett A.J. (2000). Characterization of peptidyl boronic acid inhibitors of mammalian 20S and 26S proteasomes and their inhibition of proteasomes in cultured cells. Biochem J 346: 447-454.
70. Garrison W.M. (1987). Reaction mechanisms in radiolysis of peptides, polypeptides, and proteins. Chem Rev 87: 381-398.
71. Gieche J., Mehlhase J., Licht A., Zacke T., Sitte N., Grune T. (2001). Protein oxidation and proteolysis in RAW264.7 macrophages: Effects of PMA activation. Biochim Biophys Acta 1538: 321-328.
72. Gieseg S.P., Simpson J.A., Charton T.S., Ducan M.W., Dean R.T. (1993). Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32: 4780-4786.
73. Giulivi C, Pacifici R.E., Davies K.J.A. (1994). Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch Biochem Biophys 311: 329-341.
74. Giulivi C., Traaseth N.J., Davies K.J.A. (2003). Tyrosine oxidation products: analysis and biological relevance. Amino Acids 25: 227-232.
75. Glickman M.H., Maytal V. (2002) Regulating the 26S proteasome activity. In: Zwickl P., Baumeister W. (eds.), The Proteasome-Ubiquitin Protein Degradation Pathway, Springer-Verlag, Berlin pp. 43-72.
76. Glickman M.H., Rubin D.M., Coux O., Wefes I., Pfeifer G., Cjeka Z., Baumeister W., Fried V.A., Finley D. (1998). A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94: 615-623.
77. Glotzer M., Murray A.W., Kirschner M.W. (1991). Cyclin is degraded by the ubiquitin pathway. Nature 349: 132-138.
78. Goldberg A.L. (2003). Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
79. Grandhee S., Monnier V.M. (1991). Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 266: 11649-11653.
80. Grant A.J., Jessup W., Dean R.T. (1992). Accelerated endocytosis and incomplete catabolism of radical-damaged protein. Biochim Biophys Acta 1134: 203-209.
81. Groll M., Bajorek M., Koehler A., Moroder L., Rubin D., Huber R., Glickman M.H., Finley D. (2000a). A gated channel into the core particle of the proteasome. Nat Struct Biol 7: 1062-1067.
82. Groll M., Ditzel I., Löwe J., Stock D., Bochtler M., Bartunik H.D., Huber R. (1997). Structure of 20S proteasome form yeast at 2.4 °A resolution. Nature 386: 463-471.
83. Groll M., Kim K.B., Kairies N., Huber R., Crews C.M. (2000b). Crystal structure of epoxymicin: 20S Proteasome reveals a molecular basis for selectivity of α',β'-epoxyketone proteasomal inhibitors. J Am Chem Soc 122: 1237-1238.
84. Groll M., Koguchi Y., Huber R., Kohno J. (2001). Crystal structures of the 20S proteasome TMC-95A complex: A non-covalent proteasome inhibitor. J Mol Biol 311: 543-548.
85. Grune T., Blasig I.E., Sitte N., Roloff B., Haseloff R., Davies K.J. (1998). Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem 273: 10857-10862.
86. Grune T., Jung T., Merker K., Davies K.J.A. (2004). Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and "aggresomes" during oxidative stress, aging, and disease. Int J Biochem Cell Biol 36: 2519-2530.
87. Grune T., Klotz L.O., Gieche J., Rudeck M., Sies H. (2001). Protein oxidation and proteolysis by the nonradical oxidants singlet oxygen or peroxynitrite. Free Radic Biol Med 30: 1243-1253.
88. Grune T., Reinheckel T., Davies K.J. (1996). Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem 271: 15504-15509.
89. Grune T., Reinheckel T., Davies K.J.A. (1997). Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526-534.
90. Grune T., Reinheckel T., Joshi M., Davies K.J. (1995). Proteolysis in cultured liver epithelial cells during oxidative stress: Role of the multicatalytic proteinase complex, proteasome. J Biol Chem 270: 2344-2351.
91. Grune T., Reinheckel T., Li R., North J.A., Davies K.J. (2002). Proteasome-dependent turnover of protein disulfide isomerase in oxidatively stressed cells. Arch Biochem Biophys 397: 407-413.
92. Guttman R.J., Johnson G.V. (1998). Oxidative stress inhibits calpain activity in situ. J Biol Chem 273: 13331-13338.
93. Harding C.V., France J., Song R., Farah J.M., Chatterjee S., Iqbal M., Siman R. (1995). Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigenprocessing pathway. J Immunol 255: 1767-1775.
94. Harper J.W., Powers J.C. (1985). Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors. Biochemistry 25: 7200-7213.
95. Hawkins C.L., Davies M.J. (1999). Hypochlorite-induced oxidation of proteins in plasma: Formation of chloramines and nitrogen-centered radicals and their role in protein fragmentation. Biochem J 340: 539-548.
96. Hawkins C.L., Pattison D.I., Davies M.J. (2003). Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 25: 259-274.
97. Hayashi T., Goto S. (1998). Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech Aging Dev 102: 55-66.
98. Headlam H.A., Davies M.J. (2004). Markers of protein oxidation: Different oxidants give rise to variable yields of bound and released carbonyl products. Free Rad Biol Med 36: 1175-1184.
99. Heinecke J.W., Hsu F.F., Crowley J.R., Hazen S.L., Leeuwenburgh C., Mueller D.M., Rasmussen J.E., Turk J. (2000). Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Meth Enzymol 300: 124-144.
100. Herold S. (2004). Nitrotyrosine, dityrosine and nitrotryptophan formation form metmyoglobin, hydrogen peroxide and nitrite. Free Rad Biol Med 36: 565-579.
101. Hicke L. (1999). Getting down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol 9: 107-112.
102. Hicke L. (2001). A new ticket for entry into budding vesicles-ubiquitin. Cell 106: 527-530.
103. Hill C.P., Masters E.I., Whitby F.G. (2002) The 11S regulators of 10S proteasome activity. In: Zwickl P., Baumeister W. (eds.), The Proteasome-Ubiquitin Protein Degradation Pathway, Springer-Verlag, Berlin pp. 73-89.
104. Hoffmann T., Bier H., Donnenberg A.D., Whiteside T.L., De Leo A.B. (2005). p54 as an immunotherapeutic target in head and neck cancer. Adv Otorhinolaryngol 62: 151-160.
105. Hofmann K., Falquet L. (2001). A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation system. Trends Biochem Sci 26: 347-350.
106. Holmgren A. (1989). Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966.
107. Hopper N.M. (2003). Could inhibition of the proteasome cause mad cow disease? Trends Biotechnol 115: 941-948.
108. Ibrahim M., Upreti R.K., Kidwai A.M. (1994). Calpain from rat intestinal epithelial cells: Age-dependent dynamics during cell differentiation. Mol Cell Biochem 131: 49-59.
109. Ishihara I, Minami Y., Nishizaki T., Matsuoka T., Yamamura H. (2000). Activation of calpain precedes morphological alterations during hydrogen peroxide-induced apoptosis in neuronally differentiated mouse embryonal carcinoma P19 cell line. Neurosci Lett 279: 97-100.
110. Jessup W., Mander E.L., Dean R.T. (1992). The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim Biophys Acta 1126: 167-177.
111. Johnson D.E. (2000). Non-caspase proteases in apoptosis. Leukemia 14: 1695-1703.
112. Kang Y.C., Kim P.K., Choi B.M., Chung H.T., Ha K.S., Kwon Y.G., Kim Y.M. (2004). Regulation of programmed cell death in neuronal cells by nitric oxide. In vivo 18: 367-376.
113. Karlsson J.O., Blennow K., Janson I., Bombren K., Barlsson I., Regland B., Wallin A., Gottfries C.G. (1995). Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease. Neurobiol Aging 16: 901-906.
114. Keck S., Nitsch R., Grune T., Ullrich O. (2003). Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 85: 115-122.
115. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. (1997). Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69: 273-284.
116. Kettle A.J. (1996). Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett 379: 103-106.
117. Kim P.K., Kwon Y.G., Chung H.T., Kim YM. (2002). Regulation of caspases by nitric oxide. Ann NY Acad Sci 962: 42-52.
118. Kohno J., Koguchi Y., Niskio M., Nakao K., Kuroda M., Shimizu R., Ohnuki T., Komatsubara S. (2000). Structures of TMC-95A-D: Novel proteasome inhibitors from Apoispore montagnei Sac. TC 1093. J Org Chem 65: 990-995.
119. Lakhani S., Flavell R.A. (2003). Caspases and T lymphocytes: a flip to the coin? Immunol Rev 193: 22-30.
120. Lasch P., Petras T., Ullrich O., Backmann J., Naumann D., Grune T. (2001). Hydrogen peroxide-induced structural alterations of RNAse A. J Biol Chem 276: 9492-9502.
121. Lavie L., Reznick A.Z., Gershon D. (1982). Decreased protein and puromycinyl-peptide degradation in livers of senescent mice. Biochem J 202: 47-51.
122. Lee C.K., Klopp R.G., Weindruck R., Prolla T.A. (1999). Gene expression profile of ageing and its retardation by caloric restriction. Science 285: 1390-1393.
123. Lee D.H., Goldberg A.L. (1996). Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem 271: 27280-27284.
124. Leigh P.N., Anderton B.H., Dodson A., Gallo J.M., Swash M., Power D.M. (1988). Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett 93: 197-203.
125. Leist M., Jaattela M. (2001a). Triggering of apoptosis by cathepsins. Cell Death Differ 8: 324-326.
126. Leist M., Jaattela M. (2001b). Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2: 589-598.
127. Levine R.L., Berlett B.S., Moskovitz J., Mosoni L., Stadtman E.R. (1999). Methionine residues may protect proteins from critical oxidative damage. Mech Ageing Dev 107: 323-332.
128. Levine R.L., Mosoni L., Berlett B.S., Stadtman E.R. (1996). Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 93: 15036-15040.
129. Levine R.L., Moskovitz J., Stadtman E.R. (2000). Oxidation of methionine in proteins: Roles of antioxidant defense and cellular regulation. IUBMB Life 50: 301-307.
130. Li X.C., Gu M.Z., Etlinger J.D. (1991). Isolation and characterization of a novel endogenous inhibitor of the proteasome. Biochemistry 30: 9709-9715.
131. Li X.S., Etlinger J.D. (1992). Ubiquitinated proteasome inhibitor is a component of the 26S proteasome complex. Biochemistry 31: 11964-11967.
132. Liu C.L., Martone M.E., Hu B.R. (2004). Protein ubiquitination in postsynaptic densities after transient cerebral ischemia. J Cereb Blood Flow Metab 24: 1219-1225.
133. Löwe J., Stock D., Jap B., Zwickl. P., Baumeister W., Huber R. (1995). Crystal structure of the 20S proteasome from the archaeon . acidophilum at 3.4 °A resolution. Science 268: 533-539.
134. Loidl G., Groll M., Musiol H.J., Huber R., Moroder L. (1999). Bivalency as a principle for proteasome inhibition. Proc Natl Acad Sci USA 95: 5418-5422.
135. Loidl G., Musiol H.J., Groll M., Huber R., Moroder L. (2000). Synthesis of bivalent inhibitors of eucaryotic proteasomes. J Pept Sci 66: 36-46.
136. Ly D.H., Lockhart D.J., Lerner R.A., Schultz P.G. (2000). Mitotic misregulation and human aging. Science 287: 2486-2492.
137. Ma J., Lindquist S. (2002). Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 198: 1785-1788.
138. Ma J., Wollmann R., Lindquist S. (2002). Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298: 1781-1785.
139. Mahidhara R.S., Hoffman R.A., Huang S., Wolf-Johnston A., Vodovotz Y., Simmons R.L., Billiar T.R. (2003). Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 74: 403-411.
140. Malencik D.A., Anderson S.R. (2003). Dityrosine as product of oxidative stress and fluorescent probe. Amino Acids 25: 233-247.
141. Martin J.B. (1999). Molecular basis of the neurodegenerative disorders. N Engl J Med 340: 1970-1980.
142. Marques C., Pereira P., Taylor A., Liang J.N., Reddy V.N., Szweda L.I., Shang F. (2004). Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells. FASEB J 18: 1424-1426.
143. Martinon F., Burns K., Tschopp J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 426-427.
144. Maskos Z., Rush J.D., Koppenol W.H. (1992). The hydroxylation of phenylalanine and tyrosine: A comparison with salicylate and tryptophan. Arch Biochem Biophys 296: 651-654.
145. McCracken E., Dewar D., Hunter A.J. (2001). White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res 892: 329-335.
146. McKintosh E., Tabrizi S.J., Collinge J. (2003). Prion diseases. J Neurovirol 9: 183-193.
147. Mecocci P., MacGarvey U., Beal M.V. (1994). Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36: 747-751.
148. Mehlhase J., Gieche J., Ullrich O., Sitte N., Grune T. (2000). LPS-induced protein oxidation and proteolysis in BV-2 microglial cells. IUBMB Life 50: 1-5.
149. Mehlhase J., Grune T. (2002). Proteolytic response to oxidative stress in mammalian cells. Biol Chem 383: 559-567.
150. Mehlhase J., Sandig G., Pantopoulos K., Grune T. (2005). Oxidation-induced ferritin turnover in microglial cells: Role of the proteasome. Free Radic Biol Med 38: 276-285.
151. Merker K., Grune T. (2004) Age-related changes in the degradation of oxidized proteins. In: Ö zben T., Chevion M. (eds.), Frontiers in Neurodegenerative Disorders and Aging: Fundamental Aspects, Clinical Perspectives and New Insights, IOS Press, Amsterdam pp. 1-9.
152. Merker K., Stolzing A., Grune T. (2001). Proteolysis, caloric restriction and aging. Mech Ageing Dev 122: 595-615.
153. Naskalski J.W., Bartosz G. (2000). Oxidative modification of protein structures. Adv Clin Chem 35: 161-253.
154. Niedermann G. (2002) Immunological functions of the proteasome. In: Zwickl P., Baumeister W. (eds.), The Proteasome-Ubiquitin Protein Degradation Pathway, Springer-Verlag, Berlin pp. 91-136.
155. Okada A.A., Dice J.F. (1984). Altered degradation of intracellular proteins in aging human fibroblasts. Mech Aging Dev 26: 341-356.
156. Orlowski M., Cardozo C., Michaud C. (1993). Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex: Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32: 1563-1572.
157. Palmer J.T., Rasnick D., Klaus J.L., Bromme D. (1995). Vinyl sulfones as mechanismbased cysteine protease inhibitors. J Med Chem 38: 3193-3196.
158. Palombella V.J., Rando O.J., Goldberg A.L.,Maniatis T. (1994). The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785.
159. Pacifici R.E., Kono Y., Davies K.J.A. (1993). Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem 268: 15405-15411.
160. Perrin B.J., Huttenlocher A. (2002). Calpain. Int J Biochem Cell Biol 34: 722-725.
161. Peters J.-M., Franke W.W., Kleinschmidt J.A. (1994). Distinct 19S and 20S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 269: 7709-7718.
162. Peters J.-M., Harris J.R., Finley D. (eds.). (1998). Ubiquitin and the Biology of the Cell, Plenum Press, New York.
163. Petropoulos I., Conconi M., Wang X., Hoenel B., Bregegere F., Milner Y., Friguet B. (2000). Increase of oxidatively modified protein is associated with a decrease of proteasomal activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 55: 220-227.
164. Pickart C. (2000). Ubiquitin in chains. Trends Biochem Sci 25: 544-548.
165. Poston J.M. (1988). Detection of oxidized amino acid residues using P-aminobenzoic acid adducts. Fed Proc 46: 1979.
166. Prusiner S.B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
167. Rami A. (2003). Ischemic neuronal death in the rat hippocampus: The calpain-calpastatincaspase hypothesis. Neurobiol Dis 13: 75-88.
168. Rammensee H.G., Falk K., Rotzschke O. (1993). Peptides naturally presented by JHC class I molecules. Ann Rev Immunol 11: 213-244.
169. Rao G., Fisch L., Srinivasan S., D'Amico F., Okada T., Eaton C., Robbins C. (2003). Does this patient have Parkinson's disease? JAMA 289: 347-353.
170. Rechsteiner M. (1998). The 26S proteasome. In Peters J.M., Harris J.R, Finley D. (eds.). Ubiquitin and the Biology of the Cell, Plenum Press, New York.
171. Rechsteiner M., Realini C., Ustrell V. (2000). The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochem J 345: 1-15.
172. Reinheckel T., Sitte., Ullrich O., Kuckelkorn U., Davies K.J., Grune T. (1998). Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335: 637-642.
173. Reinheckel T., Ullrich O., Sitte N., Grune T. (2000). Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 377: 65-68.
174. Renard C.B., Kramer F., Johansson F., Lamharzi N., Tannock L.R., von Herrath M.G., Chait A., Bornfeldt K.E. (2004). Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. Clin Invest 114: 659-668.
175. Requena J.R., Chao C.C., Levine R.L., Stadtman E.R. (2001). Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 98: 69-74.
176. Requena J.R., Levine R.L., Stadtman E.R. (2003). Recent advances in the analysis of oxidized proteins. Amino Acids 25: 221-226.
177. Requena J.R., Dimitrova M.N., Legname G., Teijeira S., Prusiner S.B., Levine R.L. (2004). Oxidation of methionine residues in the prion protein by hydrogen peroxide. Arch Biochem Biophys 432: 188-195.
178. Rivett A.J. (1985). Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases. J Biol Chem 260: 300-305.
179. Rivett A.J. (1998). Intracellular distribution of proteasomes. Curr Opin Immunol 10: 110-114.
180. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771.
181. Ron D., Oyadomari S. (2004). Lipid phase perturbation and the unfolded protein response. Dev Cell 7: 287-288.
182. Rosenblatt A., Margolis R.L., Becher M.W., Aylward E., Franz M.L., Sherr M., Abbott M.H., Lian K.Y., Ross C.A. (1998). Does CAG repeat number predict the rate of pathological changes in Huntington's disease? Ann Neurol 44: 708-709.
183. Ross C.A. (2002). Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntingtons' disease and related disorders. Neuron 35: 819-822.
184. Rowland L.P. (1994). Amyotrophic lateral sclerosis. Curr Opin Neurol 8: 310-315.
185. Saitoh Y., Yokosawa H., Ishii S. (1989). Sodium Dodecyl sulfate-induced conformational and enzymatic changes of multicatalytic proteinase. Biochem Biophys Res Commun 162: 334-339.
186. Salo D.C., Pacifici R.E., Lin S.W., Giulivi C., Davies K.J. (1990). Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem 265: 11919-11927.
187. Salo D.C., Lin S.W., Pacifici R.E., Davies K.J. (1988). Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide. Free Radic Biol Med 5: 335-339.
188. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66.
189. Savory P.J., Djaballah H., Angliker H., Shaw E., Rivett A.J. (1993). Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes. Biochem J 296: 601-605.
190. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. (1990). Mitochondrial complex I deficiency in Parkinsons's disease. J Neurochem 54: 823-827.
191. Schwerk C., Schulze-Osthoff K. (2003). Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 66: 1453-1458.
192. Seeger M., Ferrell K., Frank R., Dubiel W. (1997). HIV-1 tat inhibits the 20S proteasome and its 22S regulator-mediated activation. J Biol Chem 272: 8145-8148.
193. Seo M.S., Kim J.K., Lim Y., Kang S.W., Cho Y.J., Lee W.K., Kim H.J., Cho K.K., Lee K.H., Rhee S.G. (1999). Rapid degradation of Prxl and PrxII induced by silica in Rat2 cells. Biochem Biophys Res Commun 265: 541-544.
194. Sheaff R.J., Singer J.D., Swanger J., Smitherman M., Roberts J.M., Clurman B.E. (2000). Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Molecular Cell 5: 403-410.
195. Shih S.C., Sloper-Mould K.E., Hicke L. (2000). Monoubiquitin carries a novel internalization signal that is appended to activated receptors. EMBO J 19: 187-198.
196. Shringarpure R., Grune T., Mehlhase J., Davies K.J. (2003). Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 278: 311-318.
197. Shringarpure R., Grune T., Sitte N., Davies K.J.A. (2000). 4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: Possible importance for Alzheimer's disease. Cell Mol Life Sci 57: 1802-1809.
198. Sitte N., Merker K., Grune T. (1998). Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS Lett 440: 399-402.
199. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Zglinicki T., Davies K.J.A. (2000a). Proteasome inhibition by lipofuscin/ceroid during postmitotic ageing of fibroblasts. FASEB J 14: 1490-1498.
200. Sitte N., Merker K., von Zglinicki T., Davies K.J.A., Grune T. (2000b). Protein oxidation and degradation during cellular senescence of human BJ-fibroblasts. Part I. Effects of proliferative senescence. FASEB J 14: 2495-2502.
201. Sitte N., Merker K., von Zglinicki T., Davies K.J.A., Grune T. (2000c). Protein oxidation and degradation during cellular senescence of human BJ-fibroblasts. Part II. Aging of non-dividing cells. FASEB J 14: 2503-2510.
202. Sitte N., Merker K., Grune T., von Zglinicki T. (2001). Lipofuscin accumulation in proliferating fibroblasts in vitro: An indicator of oxidative stress. Exp Gerontol 36: 475-486.
203. Smit A., Lutgers H.L. (2004). The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 11: 2767-2784.
204. Sommerburg O., Ullrich O., Sitte N., von Zglinicki D., Siems W., Grune T. (1998). Doseand wavelength-dependent oxidation of crystallins by UV light-Selective recognition and degradation by the 20S proteasome. Free Radic Biol Med 24: 1369-1374.
205. Song X., Mott J.D., von Kampen K., Pramanik B., Tanaka K., Slaughter C.A., DeMartino G.N. (1996). A model for the quaternary structure of the proteasome activator PA28. J Biol Chem 271: 26410-26417.
206. Spaltenstein A., Leban J.J., Huang J.J., Reinhardt K.R., Viveros O.H., Sigafoos J., Crouch R. (1996). Design and synthesis of novel protease inhibitors: Tripeptide α',β'-epoxyketones as nanomolar inactivators of the proteasome. Tet Lett 37: 1343-1346.
207. Stadtman E.R. (1992). Protein oxidation and aging. Science 257: 1220-1224.
208. Stadtman E.R., Levine R.L. (2003). Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25: 207-218.
209. Stern I.J., Wiley D.C. (1994). Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2: 245-251.
210. Stolzing A., Wengner A., Grune T. (2002). Degradation of oxidized extracellular proteins by microglia. Arch Biochem Biophys 400: 171-179.
211. Strickland E., Hakala K., Thomas P.J., DeMartino G.N. (2000). Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome. J Biol Chem 275: 5565-5572.
212. Strohwasser R., Salzmann U., Ruppert T., Kloetzel P.M., Holzhuetter H.G. (2000). Kinetic evidences for facilitation of peptide channeling by the proteasomal activator PA28. Eur J Biochem 267: 6221-6230.
213. Suriano G., Vrcelj N., Senz J., Ferreira P., Masoudi H., Cox K., Nabais S., Lopes C., Machado J.C., Seruca R., Carneiro F., Huntsman D.G. (2005). beta-Catenin (CTNNB1) gene amplification: A new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 42: 238-246.
214. Takahashi R., Goto S. (1990). Alteration of aminoacyl-tRNA synthetase with age: Heatlabilization of the enzyme by oxidative damage. Arch Biochem Biophys 227: 228-233.
215. Tamura T., Tamura N., Cejka Z., Hegerl R., Lottspeich F., Baumeister W. (1996). Tricorn protease-The core of a modular proteolytic system. Science 274: 1385-1389.
216. Tanaka K., Kasahara M. (1998). The MHC Class I ligand-generating system: Roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol Rev 163: 161-176.
217. Tandan R., Bradley W.G. (1985). Amyotrophic lateral sclerosi. Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 18: 271-280.
218. Tarcsa E., Szymanska G., Lecker S., O'Connor C.M., Goldberg A.L. (2000). Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by the 26S proteasome without ubiquitination. J Biol Chem 275: 20295-20301.
219. Taylor J.P., Hardy J., Fischbeck K-H. (2002). Toxic proteins in neurodegenerative diseases. Science 296: 1991-1995.
220. Terman A., Brunk U.T. (1998). Lipofuscin: Mechanisms of formation and increase with age. APMIS 106: 265-276.
221. Tomkinson B. (1999). Tripeptidyl peptidases: Enzymes that count. Trends Biochem Sci 24: 355-359.
222. Tschopp J., Martinon F., Burns K. (2003). NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4: 95-104.
223. Turk B., Turk D., Turk V. (2000). Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta 1477: 98-111.
224. Turk V., Turk B., Turk D. (2001). Lysosomal cysteine proteases: Facts and opportunities. EMBO J 20: 4629-4633.
225. Uchida K., Kawakishi S. (1993). 2-oxohistidine as a novel biological marker for oxidatively modified proteins. FEBS Lett 332: 208-210.
226. Uchida K., Stadtman E.R. (1993). Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 268: 6388-6393.
227. Uchida K. (2003). Histidine and lysine as targets of oxidative modification. Amino Acids 25: 249-257.
228. Ullrich O., Grune T. (2001). Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells. Free Radic Biol Med 31: 887-893.
229. Ullrich O., Reinheckel T., Sitte N., Grune T. (1999a). Degradation of hypochloritedamaged glucose-6-phosphate dehydrogenase by the 20S proteasome. Free Radic Biol Med 27: 487-492.
230. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., Davies K.J. (1999b). Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci USA 96: 6223-6228.
231. Ullrich O., Sitte N., Sommerburg O., Sandig V., Davies K.J., Grune T. (1999c). Influence of DNA binding on the degradation of oxidized histones by the 20S proteasome. Arch Biochem Biophys 362: 211-216.
232. Ulrich H.D. (2002a) Natural substrates of the proteasome and their recognition by the ubiquitin system. In: Zwickl P., Baumeister W. (eds.), The Proteasome-Ubiquitin Protein Degradation Pathway, Springer-Verlag, Berlin pp. 137-174.
233. Ulrich H.D. (2002b). Natural substrates of the proteasome and their recognition by the ubiquitin system. Curr Top Microbiol Immunol 268: 137-174.
234. Uversky V.N., Fink A.L. (2002). Amino acid determinants of alspha-synuclein aggregation: Putting together pieces of the puzzle. FEBS Lett 522: 9-13.
235. Van Der Vliet A., Ca O.N., Halliwell B., Cross C.E., Kaur H. (1994). Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite: Evidence for hydroxyl radical production form peroxynitrite. FEBS Lett 399: 89-92.
236. Verzyl N., de Groot J., Oldehinken E., Bank R.A., Thorpe S.R., Baynes J.W., Bayliss M.T., Bijlsma W.J., Lafeber F.P.J.G., Tekoppele J.M. (2000). Age accumulation of Maillard products in human articular cartilage collagen. Biochem J 350: 381-387.
237. Voges D., Zwickl P., Baumeister W. (1999). The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem 68: 1015-1068.
238. Volker C., Lupas A.N. (2002).Molecular evolution of proteasomes. In: Zwickl P., Baumeister W. (eds.), The Proteasome-Ubiquitin Protein Degradation Pathway, Springer-Verlag, Berlin, pp. 1-22.
239. Wagner B.J., Margolis J.W. (1995). Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor. Arch Biochem Biophys 323: 455-462.
240. Walz J., Tamura T., Tamura N., Grimm R., Baumeister W., Kloster A.J. (1997). Tricorn protease exists as an icosahedral supermolecule in vivo. Mol Cell 1: 59-65.
241. Wang K.K. (2000). Calpain and caspase: Can you tell the difference? Trends Neurosci 23: 20-26.
242. Wang N., Gottesman S., Willingham M.C., Gottesman M.M., Maurize M.R. (1993). A human mitochondrial ATP-dependent protease that is highly homologous to bacterial Lon protease. Proc Natl Acad Sci USA 90: 11247-11251.
243. Wang Y.C., Lin R.K., Tan Y.H., Chen J.T., Chen C.Y., Wang Y.C. (2005). Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: An alternative pathway to Non-small-cell lung cancer. J Clin Oncol 23: 154-164.
244. Watabe S., Kimura T. (1985). ATP-dependent protease in bovine adrenal cortex: Tissue specificity, subcellular localization and partial characterisation. J Biol Chem 260: 5511-5517.
245. Wells-Knecht K.J., Zyzak D.V., Lichtfield J.E., Thorpe S.R., Baynes J.W. (1995). Mechanism of autooxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autooxidative modification of proteins by glucose. Biochemistry 34: 3702-3709.
246. Wenzel T., Baumeister W. (1995). Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol 2: 199-204.
247. Whitby F.G., Masters E.I., Kramer L., Knowlton J.R., Yao Y., Wang C.C., Hill C.P. (2000). Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408: 115-120.
248. Willner C. (2004). An overview of the pathophysiology of neurodegenerative disorders. Altern Ther Health Med 10: 26-34.
249. Woo M., Hakem R., Furlinger C., Hakem A., Duncan G.S., Sasaki T., Bouchard D., Lu L., Wu G.E., Paige C.J., Mak T.W. (2003). Caspase-3 regulates cell cycle in B cells: A consequence of substrate specificity. Nat Immunol 4: 1016-1022.
250. Yi D., Smythe G.A., Blount B.C., Ducan M.W. (1997). Peroxynitrite-mediated nitration of peptides: characterisation of the products by electrospray and combined gas chromatography-mass spectrometry. Arch Biochem Biophys 344: 253-259.
251. York I.A., Goldberg A.L., Mo X.Y., Rock K.L. (1999). Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 172: 49-66.
252. Zhang Z., Kruchinsky A., Endicott S., Realini C., Rechsteiner M., Standing K.G. (1999). Proteasome activator 11S REG or PA28. Recombinant REGα/REGβ hetero-oligomers are heptamers. Biochemistry 38: 5651-5658.
253. Zhou J.Q., Gafni A. (1991). Exposure of rat muscle phosphoglycerate kinase ton nonenzymatic MFO system generates the old form of the enzyme. J Gerontol 46: B217-B221.
254. Zoghbi H.Y., Orr H.T. (2000). Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23: 217-247.
255. Zwickl P., Baumeister W. (eds.). (2002). The Proteasome-Ubiquitin Protein Degradation Pathway. Springer-Verlag, Berlin.